Lake Street Capital Issues Pessimistic Forecast for P3 Health Partners (NASDAQ:PIII) Stock Price

P3 Health Partners (NASDAQ:PIII) had its target price reduced by investment analysts at Lake Street Capital from $12.50 to $4.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Lake Street Capital’s target price would indicate a potential upside of 51.46% from the stock’s current price.

A number of other research analysts have also recently commented on the company. BTIG Research restated a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, P3 Health Partners currently has an average rating of “Hold” and an average target price of $4.00.

P3 Health Partners Trading Down 5.3%

PIII traded down $0.15 on Friday, hitting $2.64. 12,876 shares of the company were exchanged, compared to its average volume of 88,242. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.32 and a current ratio of 0.32. The firm has a fifty day simple moving average of $2.47 and a two-hundred day simple moving average of $5.23. The stock has a market capitalization of $19.04 million, a PE ratio of -0.07 and a beta of 0.86. P3 Health Partners has a 12 month low of $1.52 and a 12 month high of $11.30.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings data on Thursday, March 26th. The company reported ($23.02) EPS for the quarter, missing the consensus estimate of ($8.06) by ($14.96). P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%. The firm had revenue of $384.81 million for the quarter, compared to the consensus estimate of $357.65 million. Sell-side analysts expect that P3 Health Partners will post -0.67 earnings per share for the current year.

Institutional Investors Weigh In On P3 Health Partners

A hedge fund recently raised its stake in P3 Health Partners stock. Trinity Financial Advisors LLC lifted its holdings in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 26,678 shares of the company’s stock after purchasing an additional 1,178 shares during the period. Trinity Financial Advisors LLC owned about 0.37% of P3 Health Partners worth $239,000 at the end of the most recent reporting period. 7.75% of the stock is owned by hedge funds and other institutional investors.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.